Brenden Rearick

Brenden Rearick

InvestorPlace Financial News Writer

Expertise: Blockchain, Cryptocurrency, Digital Asset Regulation

Education: BA, Public & Professional Writing and Political Science, University of Pittsburgh

About Brenden:
Brenden Rearick is a Financial News Writer for the Today’s Market team at InvestorPlace, joining the team in 2021. Before joining InvestorPlace, Brenden was a student and a freelance writer, contributing to various periodicals for the University of Pittsburgh and local non-profits.

He primarily covers cryptocurrency and blockchain technology for Today’s Market. His interests span the metaverse, as well as DeFi and Web 3.0 projects.

You can follow Brenden on Twitter.

Recent Articles

NRXP Stock: This Covid-19 Treatment Could Prime NRx Pharmaceuticals for Big Gains

By Brenden Rearick, InvestorPlace Financial News Writer

NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA.

IGC Stock: The Huge Cannabis Patent News That Has IGC Flying High

By Brenden Rearick, InvestorPlace Financial News Writer

IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Brenden Rearick, InvestorPlace Financial News Writer

What will the stock market do today? It'll continue to hate the chip shortage taking automakers hostage and patiently await tech earnings.

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Brenden Rearick, InvestorPlace Financial News Writer

What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss.

SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars

By Brenden Rearick, InvestorPlace Financial News Writer

SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.

Load More